Monday, December 23, 2024
HomeIndustriesBiotechnology

Biotechnology

Prometheus Biosciences Reports Positive Topline Phase 1 Data on Lead Therapeutic Candidate PRA023; Expands Indications to Include Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)

Prometheus Biosciences, Inc. a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development and commercialization of novel therapeutic and companion diagnostic...

Aphex BioCleanse Systems Engages Milestone Management Services

Aphex BioCleanse Systems, Inc., a forward-thinking, publicly traded company, announced it has reached an agreement to engage Milestone Management Services to join their Corporate...

Vaccitech reports promising interim efficacy analysis in Phase 1b/2a clinical study in chronic HBV

Vaccitech plc, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutic and vaccines, announced a promising interim analysis of safety...

Clover Signs COVID-19 Vaccine Supply Agreement with UNICEF

Clover Biopharmaceuticals, Ltd. a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced that they have entered into a long-term...

Aligos Presents Update of Chronic Hepatitis B Pipeline Portfolio at HEP DART 2021

Aligos Therapeutics, Inc. a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, announced...
0FansLike
0FollowersFollow
spot_img

Hot Topics